SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: jack w garnes jr. who wrote (12983)8/10/1998 6:49:00 PM
From: VLAD  Read Replies (1) of 23519
 
jack,

I guess I will provide you and all with some positive tidbits of information. Since you worked for the VA and are a Vivus shareholder you probably already know this but the VA will continue to be a significant consumer of MUSE since the VA has decided that Viagra is too expensive and the large "at risk" number of VA patients makes Viagra a poor choice for the VA.Jack, maybe you can tell us about how Vivus and the VA work out contracting information and if the VA is due for a large shipment of MUSE in Q3?

Another important matter to look at is the continuing downward spiral of new Viagra scripts. Todays data revealed a new script number continuing to sink and now almost 1/3 of its highs made back in May.
The refill numbers seem to be holding at the 80 t0 85k level but I am wondering about how many of these refills are from men who did not get much success from the first Rx and are going through at least one refill before giving up on Viagra? IMO if the second refill tends to be unsuccessful, I doubt a third refill or a new script will be obtained. The next question will be, How many of these failures will go back to the PCP since many have probably skimmed the MUSE literature and know that there is another treatment option? Also, how many PCPs are comfortable prescribing MUSE vs just refering to the urologist? As long as Vivus does not have a domestic partner calling upon the PCPs, it is my opinion that in the short term anyways (one to two months) the answer to these questions will determine where domestic MUSE sales will be heading. My gut feeling is that in light of the significant decline of new Viagra scripts the Viagra party is almost over and now MUSE will get a chance to start eating the left overs and hopeful start to show a rebound in market share.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News